======= ACADS ======= == Gene Information == * **Official Symbol**: ACADS * **Official Name**: acyl-CoA dehydrogenase short chain * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=35|35]] * **UniProt**: [[https://www.uniprot.org/uniprot/P16219|P16219]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ACADS&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ACADS|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606885|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a tetrameric mitochondrial flavoprotein, which is a member of the acyl-CoA dehydrogenase family. This enzyme catalyzes the initial step of the mitochondrial fatty acid beta-oxidation pathway. Mutations in this gene have been associated with short-chain acyl-CoA dehydrogenase (SCAD) deficiency. Alternative splicing results in two variants which encode different isoforms. [provided by RefSeq, Oct 2014]. * **UniProt Summary**: Introduces a double bond at position 2 in saturated acyl-CoA's of short chain length, i.e. less than 6 carbon atoms. {ECO:0000250|UniProtKB:P15651}. |Acyl-CoA dh 2| |Acyl-CoA dh M| |Acyl-CoA dh 1| |Acyl-CoA dh N| |butyryl-CoA dehydrogenase activity| |butyrate catabolic process| |butyrate metabolic process| |acyl-CoA dehydrogenase activity| |short-chain fatty acid catabolic process| |fatty acid beta-oxidation using acyl-CoA dehydrogenase| |short-chain fatty acid metabolic process| |fatty acid beta-oxidation| |flavin adenine dinucleotide binding| |fatty acid oxidation| |lipid oxidation| |fatty acid catabolic process| |monocarboxylic acid catabolic process| |cellular lipid catabolic process| |lipid modification| |organic acid catabolic process| |carboxylic acid catabolic process| |lipid catabolic process| |fatty acid metabolic process| |mitochondrial matrix| |small molecule catabolic process| |monocarboxylic acid metabolic process| |carboxylic acid metabolic process| |cellular lipid metabolic process| |oxidation-reduction process| |oxoacid metabolic process| |organic acid metabolic process| |lipid metabolic process| |mitochondrion| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|1.74| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13086 * **Expression level (log2 read counts)**: 3.9 {{:chemogenomics:nalm6 dist.png?nolink |}}